MobiHealthNews

Insulet gets FDA nod to commercialize Omnipod Dash Insulin Management System

Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash ...
FierceBiotech

FDA issues Class I recall label to Insulet’s Omnipod Android app over incorrect bolus calculations

The FDA has handed down a Class I recall label, the agency’s most serious, to a now-corrected software issue that could have resulted in delivering ten times the desired insulin dose from Insulet’s ...
Nasdaq

Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers ...
Business Wire

Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod ® 5

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
FierceBiotech

Insulet Omnipod's 'higher-than-expected demand' helps set new revenue record

Insulet broke new ground in 2021 as its annual revenues surged past the $1 billion mark for the first time—even without a splashy new product launch that year. So, when 2022 kicked off with the ...